In our study, we have found that WRN mRNA expression level was low in 326/1977 of breast tumors (16.5%) which concur strikingly with the study by Agrelo et al. In colorectal cancers, WRN hypermethylation and depletion is associated with good response to irinotecan therapy [6]. This evidence concerns the gene WRN and colorectal cancer.